AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 11967748 — intervention group
Group type: COMPARATOR
Intervention: Bupivacaine 0.25% with sufentanil 2 microgram/ml
Number of subjects: 40
Study 11967748 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study 10402613 — intervention group
Group type: EXPERIMENTAL
Intervention: Didactic format patient education (N = 16)
Number of subjects: 33
Study 10402613 — intervention group
Group type: COMPARATOR
Intervention: Discussion of subjective experiences with schizophrenia (Control group, N = 17)
Number of subjects: 33
Study 8649183 — intervention group
Group type: EXPERIMENTAL
Intervention: 50-Hz linearly polarized magnetic fields (10 mu T)
Number of subjects: 32
Study 8649183 — intervention group
Group type: COMPARATOR
Intervention: Control group (sham-exposed)
Number of subjects: 32
Study 1428294 — intervention group
Group type: EXPERIMENTAL
Intervention: Gallopamil 50 mg single-dose
Number of subjects: 12
Study 1428294 — intervention group
Group type: EXPERIMENTAL
Intervention: Gallopamil 50 mg steady-state (after nine doses)
Number of subjects: 12
Study 1428294 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 4069259 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser evaporation
Number of subjects: 165
Study 4069259 — intervention group
Group type: COMPARATOR
Intervention: Cryosurgery
Number of subjects: 165
Study 30251577 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 30253807 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensor-based feedback
Number of subjects: 54
Study 30253807 — intervention group
Group type: COMPARATOR
Intervention: Feedback from a mirror
Number of subjects: 54
Study 30253807 — intervention group
Group type: COMPARATOR
Intervention: No feedback (control group)
Number of subjects: 54
Study 26490053 — intervention group
Group type: COMPARATOR
Intervention: No antibiotics (no-antibiotic group)
Number of subjects: 623
Study 26490053 — intervention group
Group type: EXPERIMENTAL
Intervention: CT findings
Number of subjects: 623
Study 25129631 — intervention group
Group type: EXPERIMENTAL
Intervention: Inflectional morphology elicitation in individuals with PPA
Number of subjects: 48
Study 25129631 — intervention group
Group type: COMPARATOR
Intervention: Healthy age-matched controls
Number of subjects: 48
Study 22923209 — intervention group
Group type: EXPERIMENTAL
Intervention: Multisensory temporal processing (simultaneity judgment task)
Number of subjects: 100
Study 22923209 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported symptoms of autism (Autism Spectrum Quotient questionnaire)
Number of subjects: 100
Study 20102625 — intervention group
Group type: EXPERIMENTAL
Intervention: Rehabilitation programme
Number of subjects: 344
Study 20102625 — intervention group
Group type: EXPERIMENTAL
Intervention: Education booklet
Number of subjects: 344
Study 20102625 — intervention group
Group type: EXPERIMENTAL
Intervention: Rehabilitation programme plus education booklet
Number of subjects: 344
Study 20102625 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 344
Study 17664372 — intervention group
Group type: EXPERIMENTAL
Intervention: In-treatment LV hypertrophy absence (measured by CP and SLV)
Number of subjects: 9193
Study 17664372 — intervention group
Group type: EXPERIMENTAL
Intervention: In-treatment LV hypertrophy absence (measured by SLV)
Number of subjects: 9193
Study 17664372 — intervention group
Group type: EXPERIMENTAL
Intervention: In-treatment LV hypertrophy absence (measured by CP)
Number of subjects: 9193
Study 17664372 — intervention group
Group type: EXPERIMENTAL
Intervention: Absence of in-treatment LV hypertrophy (by both SLV and CP)
Number of subjects: 9193
Study 15618782 — intervention group
Group type: EXPERIMENTAL
Intervention: Endotracheal Tube (ETT)
Number of subjects: 20
Study 15618782 — intervention group
Group type: COMPARATOR
Intervention: Laryngeal Mask Airway
Number of subjects: 20
Study 15618782 — intervention group
Group type: EXPERIMENTAL
Intervention: Both ETT and Laryngeal Mask Airway
Number of subjects: 20
Study 12239682 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimal grip span for women
Number of subjects: 70
Study 12239682 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimal grip span for men
Number of subjects: 70
Study 12239682 — intervention group
Group type: EXPERIMENTAL
Intervention: Mathematical equation for women
Number of subjects: 70
Study 10847873 — intervention group
Group type: EXPERIMENTAL
Intervention: Mutual practice visits by peers
Number of subjects: 90
Study 10847873 — intervention group
Group type: COMPARATOR
Intervention: Visits by non-physician observers
Number of subjects: 90
Study 7802522 — intervention group
Group type: EXPERIMENTAL
Intervention: Foscarnet
Number of subjects: 234
Study 7802522 — intervention group
Group type: COMPARATOR
Intervention: Ganciclovir
Number of subjects: 234
Study 1564083 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium carbonate for a minimum of 8 weeks
Number of subjects: 11
Study 1564083 — intervention group
Group type: COMPARATOR
Intervention: Placebo (in double blind crossover)
Number of subjects: 11
Study 1564083 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium carbonate
Number of subjects: 11
Study 6382987 — intervention group
Group type: EXPERIMENTAL
Intervention: Acebutolol (400 mg thrice daily)
Number of subjects: 16
Study 6382987 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (80 mg thrice daily)
Number of subjects: 16
Study 6382987 — intervention group
Group type: EXPERIMENTAL
Intervention: Acebutolol
Number of subjects: 16
Study 6382987 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 16
Study 6382987 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 16
Study 31166400 — intervention group
Group type: EXPERIMENTAL
Intervention: QMiX+MA
Number of subjects: 40
Study 31166400 — intervention group
Group type: EXPERIMENTAL
Intervention: QMiX+PUI
Number of subjects: 40
Study 31166400 — intervention group
Group type: EXPERIMENTAL
Intervention: EDTA+MA
Number of subjects: 40
Study 31166400 — intervention group
Group type: EXPERIMENTAL
Intervention: EDTA+PUI
Number of subjects: 40
Study 28789578 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated intermittent theta‐burst stimulation (aiTBS) treatment over the left dorsolateral prefrontal cortex (DLPFC)
Number of subjects: 50
Study 28789578 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 50
Study 27165185 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored work-related support consisting of three face-to-face meetings of approximately 30 minutes each, with support types A (oncological nurse), B (oncological occupational physician), or C (multidisciplinary team)
Number of subjects: 310
Study 27165185 — intervention group
Group type: COMPARATOR
Intervention: Usual care (psychosocial care without work-related discussions)
Number of subjects: 310
Study 27165185 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored work-related support
Number of subjects: 310
Study 27165185 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 310
Study 24533471 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity physical education (2 classes, n = 39)
Number of subjects: 93
Study 24533471 — intervention group
Group type: COMPARATOR
Intervention: Low-to-moderate intensity physical education (1 class, n = 20)
Number of subjects: 93
Study 24533471 — intervention group
Group type: EXPERIMENTAL
Intervention: Small-sided indoor soccer (SO)
Number of subjects: 93
Study 24533471 — intervention group
Group type: EXPERIMENTAL
Intervention: Basketball (BB)
Number of subjects: 93
Study 24533471 — intervention group
Group type: EXPERIMENTAL
Intervention: Unihockey (UH)
Number of subjects: 93
Study 24533471 — intervention group
Group type: COMPARATOR
Intervention: Circuit training (CT)
Number of subjects: 93
Study 24533471 — intervention group
Group type: COMPARATOR
Intervention: Walking (W)
Number of subjects: 93
Study 24533471 — intervention group
Group type: COMPARATOR
Intervention: Nintendo Wii Boxing (NWB)
Number of subjects: 93
Study 24533471 — intervention group
Group type: COMPARATOR
Intervention: Nintendo Wii Tennis (NWT)
Number of subjects: 93
Study 22695239 — intervention group
Group type: EXPERIMENTAL
Intervention: Solabegron 125 mg
Number of subjects: 258
Study 22695239 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 258
Study 20056957 — intervention group
Group type: EXPERIMENTAL
Intervention: Gain-framed counseling
Number of subjects: 2032
Study 20056957 — intervention group
Group type: COMPARATOR
Intervention: Standard-care counseling
Number of subjects: 2032
Study 17515259 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid angioplasty and stenting (CAS)
Number of subjects: 0
Study 17515259 — intervention group
Group type: COMPARATOR
Intervention: Carotid endarterectomy (CEA)
Number of subjects: 0
Study 15616847 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training (S)
Number of subjects: 31
Study 15616847 — intervention group
Group type: COMPARATOR
Intervention: Endurance training (E)
Number of subjects: 31
Study 15616847 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined resistance and endurance training (SE)
Number of subjects: 31
Study 12140402 — intervention group
Group type: EXPERIMENTAL
Intervention: Latanoprost 0.005%
Number of subjects: 54
Study 9987165 — intervention group
Group type: EXPERIMENTAL
Intervention: Diphtheria antitoxin (> 0.01 IU ml‐1)
Number of subjects: 5187
Study 9987165 — intervention group
Group type: EXPERIMENTAL
Intervention: Age-related susceptibility
Number of subjects: 5187
Study 9987165 — intervention group
Group type: EXPERIMENTAL
Intervention: Diphtheria antitoxin levels
Number of subjects: 5187
Study 7567643 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactitol (250-400 mg/kg/day)
Number of subjects: 51
Study 7567643 — intervention group
Group type: COMPARATOR
Intervention: Lactulose (500-750 mg/kg/day)
Number of subjects: 51
Study 2187272 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5 litre regimen supplemented with bisacodyl
Number of subjects: 32
Study 2187272 — intervention group
Group type: COMPARATOR
Intervention: 4 litre regimen of a solution of electrolytes and polyethylenglycol
Number of subjects: 32
Study 665565 — intervention group
Group type: EXPERIMENTAL
Intervention: High fiber diet containing fruits and vegetables
Number of subjects: 12
Study 665565 — intervention group
Group type: COMPARATOR
Intervention: Low fiber diet containing fruit and vegetable juices
Number of subjects: 12
Study 31455295 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil 0.3 μg/kg (diluted to 2 ml) 1 min before sufentanil injection
Number of subjects: 84
Study 31455295 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (NS) 2 ml at the same time point as sufentanil injection
Number of subjects: 84
Study 31455295 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil 0.3 μg/kg
Number of subjects: 84
Study 31455295 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (NS)
Number of subjects: 84
Study 28984746 — intervention group
Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 44
Study 28984746 — intervention group
Group type: COMPARATOR
Intervention: Perphenazine
Number of subjects: 44
Study 25940230 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet supplemented with extra-virgin olive oil (EVOO)
Number of subjects: 7447
Study 25940230 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet supplemented with nuts
Number of subjects: 7447
Study 25940230 — intervention group
Group type: COMPARATOR
Intervention: Control diet (advice on a low-fat diet)
Number of subjects: 7447
Study 23584080 — intervention group
Group type: EXPERIMENTAL
Intervention: Gait speed
Number of subjects: 241
Study 23584080 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking distance
Number of subjects: 241
Study 23584080 — intervention group
Group type: EXPERIMENTAL
Intervention: Gait speed adjusted for confounding
Number of subjects: 241
Study 20889287 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild hypothermia therapy (body temperature maintained at 32.7°C for 72 hours)
Number of subjects: 81
Study 20889287 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild hypothermia therapy
Number of subjects: 81
Study 20889287 — intervention group
Group type: COMPARATOR
Intervention: Normothermia
Number of subjects: 81
Study 19331473 — intervention group
Group type: EXPERIMENTAL
Intervention: New slowly backward-rotating shift schedule
Number of subjects: 118
Study 19331473 — intervention group
Group type: COMPARATOR
Intervention: Initial fast forward-rotating shift schedule
Number of subjects: 118
Study 17086911 — intervention group
Group type: EXPERIMENTAL
Intervention: Oromucosal cannabis-based medicine (CBM)
Number of subjects: 137
Study 15589385 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine 80 mg/day
Number of subjects: 367
Study 15589385 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine 120 mg/day
Number of subjects: 367
Study 15589385 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine 20 mg QD
Number of subjects: 367
Study 15589385 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 367
Study 11759100 — intervention group
Group type: EXPERIMENTAL
Intervention: UltraSeal XT plus (filled sealant with drying agent)
Number of subjects: 180
Study 11759100 — intervention group
Group type: EXPERIMENTAL
Intervention: Delton (unfilled sealant)
Number of subjects: 180
Study 11759100 — intervention group
Group type: EXPERIMENTAL
Intervention: Air abrasion with acid etch
Number of subjects: 180
Study 11759100 — intervention group
Group type: COMPARATOR
Intervention: Bur with acid etch
Number of subjects: 180
Study 9263279 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral glutamine supplementation after exhaustive exercise
Number of subjects: 0
Study 9263279 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral glutamine supplementation
Number of subjects: 0
Study 9263279 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 7522283 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine (5-10 mg o.d.)
Number of subjects: 45
Study 7522283 — intervention group
Group type: COMPARATOR
Intervention: Captopril (25-50 mg b.i.d.)
Number of subjects: 45
Study 7522283 — intervention group
Group type: EXPERIMENTAL
Intervention: Both amlodipine and captopril
Number of subjects: 45
Study 2891533 — intervention group
Group type: EXPERIMENTAL
Intervention: Flosequinan
Number of subjects: 16
Study 2891533 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 30761787 — intervention group
Group type: EXPERIMENTAL
Intervention: Transvesical prostatic adenomectomy (TPA)
Number of subjects: 39
Study 30761787 — intervention group
Group type: EXPERIMENTAL
Intervention: Bipolar transurethral resection (TUR)
Number of subjects: 39
Study 30761787 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostate artery embolization (PAE)
Number of subjects: 39
Study 27604979 — intervention group
Group type: COMPARATOR
Intervention: Placebo-controlled trials
Number of subjects: 0
Study 25638616 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic Nissen fundoplication (LN)
Number of subjects: 39
Study 25638616 — intervention group
Group type: COMPARATOR
Intervention: Open Nissen fundoplication (ON)
Number of subjects: 39
Study 23302515 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibular reposition taping (FRT)
Number of subjects: 12
Study 23302515 — intervention group
Group type: COMPARATOR
Intervention: Sham tape intervention
Number of subjects: 12
Study 20381287 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefuroxime
Number of subjects: 3
Study 20381287 — intervention group
Group type: EXPERIMENTAL
Intervention: Fusidic acid
Number of subjects: 3
Study 20381287 — intervention group
Group type: EXPERIMENTAL
Intervention: Vancomycin
Number of subjects: 3
Study 18958167 — intervention group
Group type: EXPERIMENTAL
Intervention: High levels of media reporting on diseases
Number of subjects: 0
Study 18958167 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent presentation of objective information about diseases
Number of subjects: 0
Study 18958167 — intervention group
Group type: COMPARATOR
Intervention: Low media frequency conditions
Number of subjects: 0
Study 15723892 — intervention group
Group type: EXPERIMENTAL
Intervention: CBSM+ intervention (10-week group cognitive-behavioral stress management/expressive supportive therapy)
Number of subjects: 0
Study 12830458 — intervention group
Group type: EXPERIMENTAL
Intervention: T + V (Trandolapril 2 mg + Verapamil 180 mg)
Number of subjects: 69
Study 12830458 — intervention group
Group type: EXPERIMENTAL
Intervention: T + A (Trandolapril 2 mg + Amlodipine 5 mg)
Number of subjects: 69
Study 12830458 — intervention group
Group type: COMPARATOR
Intervention: T + A
Number of subjects: 69
Study 12830458 — intervention group
Group type: COMPARATOR
Intervention: T + V
Number of subjects: 69
Study 10390406 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciclesonide 50 micrograms
Number of subjects: 29
Study 8895271 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl 100 micrograms (Group I)
Number of subjects: 80
Study 8895271 — intervention group
Group type: COMPARATOR
Intervention: Ketorolac 60 mg (Group II)
Number of subjects: 80
Study 2000278 — intervention group
Group type: EXPERIMENTAL
Intervention: Early surfactant (given at birth)
Number of subjects: 182
Study 2000278 — intervention group
Group type: EXPERIMENTAL
Intervention: Late surfactant (given at less than 6 hours of age)
Number of subjects: 182
Study 2000278 — intervention group
Group type: COMPARATOR
Intervention: Control (dummy instillation of air given at birth)
Number of subjects: 182
Study 6594786 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride-containing sucking tablet (Fludent, 0.25 mg F) daily at bedtime for 3 years
Number of subjects: 34
Study 6594786 — intervention group
Group type: COMPARATOR
Intervention: Control group (no fluoride tablet)
Number of subjects: 34
Study 30538282 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS
Number of subjects: 12
Study 30538282 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 12
Study 28183322 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist-led medication review
Number of subjects: 1400
Study 28183322 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1400
Study 29071950 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture treatment (3 months duration)
Number of subjects: 130
Study 29071950 — intervention group
Group type: COMPARATOR
Intervention: Routine rehabilitation therapy (Control group)
Number of subjects: 130
Study 22942273 — intervention group
Group type: EXPERIMENTAL
Intervention: Email-delivered intervention promoting fruit and vegetable consumption, consisting of an implementation intention 'planning task' and between 3 and 15 short email messages over a 15-day study period.
Number of subjects: 110
Study 22942273 — intervention group
Group type: EXPERIMENTAL
Intervention: Email-delivered intervention promoting fruit and vegetable consumption
Number of subjects: 110
Study 22545609 — intervention group
Group type: EXPERIMENTAL
Intervention: Strong tests (high strength list studied 5 times)
Number of subjects: 0
Study 22545609 — intervention group
Group type: COMPARATOR
Intervention: Weak tests (low strength list studied once)
Number of subjects: 0
Study 19777216 — intervention group
Group type: EXPERIMENTAL
Intervention: Cocaine craving during periods of urine-verified cocaine use
Number of subjects: 112
Study 19777216 — intervention group
Group type: EXPERIMENTAL
Intervention: Cocaine craving during the 5 hours prior to cocaine use
Number of subjects: 112
Study 19777216 — intervention group
Group type: COMPARATOR
Intervention: Heroin craving and mood ratings
Number of subjects: 112
Study 17900364 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole milk (710 ml daily for one month)
Number of subjects: 74
Study 17900364 — intervention group
Group type: EXPERIMENTAL
Intervention: Low fat (2%) milk (710 ml for one week)
Number of subjects: 74
Study 17900364 — intervention group
Group type: COMPARATOR
Intervention: Macronutrient substitute for milk (one week)
Number of subjects: 74
Study 16078129 — intervention group
Group type: EXPERIMENTAL
Intervention: Stretching exercises performed three times a day starting the morning after surgery
Number of subjects: 409
Study 16078129 — intervention group
Group type: EXPERIMENTAL
Intervention: Stretching exercises
Number of subjects: 409
Study 16078129 — intervention group
Group type: COMPARATOR
Intervention: Control group (no stretching exercises)
Number of subjects: 409
Study 12090906 — intervention group
Group type: EXPERIMENTAL
Intervention: 12.5 mg (R)-carvedilol
Number of subjects: 23
Study 12090906 — intervention group
Group type: EXPERIMENTAL
Intervention: 12.5 mg (S)-carvedilol
Number of subjects: 23
Study 12090906 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 mg (R,S)-carvedilol
Number of subjects: 23
Study 12090906 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 mg (R,S)-carvedilol (in patients with essential arterial hypertension)
Number of subjects: 23
Study 10417506 — intervention group
Group type: EXPERIMENTAL
Intervention: (+)‐tramadol
Number of subjects: 98
Study 10417506 — intervention group
Group type: EXPERIMENTAL
Intervention: racemate
Number of subjects: 98
Study 10417506 — intervention group
Group type: EXPERIMENTAL
Intervention: (‐)‐tramadol
Number of subjects: 98
Study 7675047 — intervention group
Group type: EXPERIMENTAL
Intervention: DTP toxoids
Number of subjects: 3448
Study 7675047 — intervention group
Group type: COMPARATOR
Intervention: DT toxoids
Number of subjects: 3448
Study 7675047 — intervention group
Group type: EXPERIMENTAL
Intervention: DTP toxoids after two doses
Number of subjects: 3448
Study 2187551 — intervention group
Group type: EXPERIMENTAL
Intervention: Silver alloy coated Foley catheter
Number of subjects: 223
Study 2187551 — intervention group
Group type: COMPARATOR
Intervention: Teflonised latex Foley catheter
Number of subjects: 223
Study 7029988 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid (ASA) 2 g/die for 30 days
Number of subjects: 14
Study 7029988 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 14
Study 30856025 — intervention group
Group type: EXPERIMENTAL
Intervention: Fennel infusion plus dry cupping
Number of subjects: 61
Study 30856025 — intervention group
Group type: COMPARATOR
Intervention: Metformin
Number of subjects: 61
Study 27605588 — intervention group
Group type: EXPERIMENTAL
Intervention: PCV11
Number of subjects: 11729
Study 27605588 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11729
Study 27521997 — intervention group
Group type: EXPERIMENTAL
Intervention: RAR CLA (6g per day for 8 weeks)
Number of subjects: 65
Study 27521997 — intervention group
Group type: COMPARATOR
Intervention: Placebo (high oleic sunflower oil)
Number of subjects: 65